GATC 2026: Genetic Agency Technology Conference

​About GATC

​Dyno is working to build a world with genetic agency. To advance this vision, Dyno will host the second Genetic Agency Technology Conference (GATC) in San Francisco on Wednesday, November 18.

​GATC explores how frontier AI and genetic technologies are accelerating medicine. The one-day conference brings together patients, AI pioneers, technologists, entrepreneurs, and therapeutic developers committed to translating emerging technologies into patient impact.

​“It’s one of the most purposeful conferences I’ve attended in a long time.”
Samantha Piteri-Molina, Forge Biologics

​Why Attend?

​Hear directly from patients shaping the next generation of genetic technologies. Meet collaborators across the gene therapy ecosystem. Explore the scientific and technological trends defining what comes next. Leave with the relationships and conviction needed to realize a world with genetic agency.

​GATC Comes to San Francisco

​Last year's inaugural GATC in Boston brought together more than 200 participants for candid discussion, meaningful collaboration and a shared effort to move genetic medicine from scientific foundations to patient impact.

​Speakers

​This year’s speakers include patient advocates and therapeutic developers with a personal connection to genetic agency, as well as scientists and entrepreneurs pioneering new genetic medicines. Please refer to our website for the most up-to-date list.

​Why Genetic Agency?

​Genetic agency is an individual’s ability to take action at the genetic level to live a healthier life. Dyno CEO Eric Kelsic introduced the term last year to highlight the importance of creating therapeutic options where none exist today, and to recognize the efforts of patients and their families who work to develop these medicines themselves rather than give up hope.

​As AI and genetic technologies improve, GATC convenes the people best positioned to accelerate treatments once considered unimaginable.

​What to Expect?

​GATC 2026 will explore patient stories, AI-driven sequence design, therapeutic development, frontier genetic technologies, preclinical translation, manufacturing, and regulatory pathways.

​Unlike conventional conferences, GATC prioritizes candid, cross-disciplinary collaboration. Attendees come prepared to contribute their expertise and co-create the next generation of genetic medicines.

​GATC is invitation-only, with a limited number of spaces available. Visit dynotx.com/gatc2026 for updates or contact gatc@dynotx.com with event-specific questions.